Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 29 Apr 24 RW Registration withdrawal request
- 24 Apr 24 S-1/A IPO registration (amended)
-
19 Apr 24 S-1/A IPO registration (amended)
- 25 Mar 24 S-1 IPO registration
CYCC similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in this Amendment No. 1 to the Registration Statement (No. 333-278197) on Form S-1 of Cyclacel Pharmaceuticals, Inc. and subsidiaries of our report dated March 21, 2024, relating to the consolidated financial statements of Cyclacel Pharmaceuticals, Inc. and subsidiaries, appearing in the Annual Form 10-K of Cyclacel Pharmaceuticals, Inc. for the year ended December 31, 2023.
We also consent to the reference to our firm under the heading “Experts” in such Prospectus.
/s/ RSM US LLP
New York, New York
April 19, 2024